Chesapeake — Investor Presentation (April 2006)
31 slides from Chesapeake's investor presentation, Apr 11, 2006
Slide 1: Investing In Chesapeake
Exhibit 99.1 Investing In Chesapeake April 2006
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause Chesapeake's ac
Slide 3: Business and Strategic Overview
Business and Strategic Overview
Slide 4: Company Overview
Company Overview NYSE Symbol: CSK Share Ownership Shares Outstanding: 19.6 million Market Capitalization: $333 million 75% Annual Dividend: $0.88 / share Top Five Institutional Shareholders: T. Rowe Price Dimensional Fund Advisors 7% 18% Wells Capital Mgmt. / Benson / Strong Barclays Global Investor
Slide 5: Investment Highlights
Investment Highlights A leading supplier of value-added, specialty paperboard packaging in Europe A leading supplier of specialty plastic packaging products to niche end-use markets Focus on higher growth, lower cyclicality end-use markets that require rigorous process & quality control, brand posit
Slide 6: Company Overview
Company Overview 2005 Sales by Market 2005 Sales by Geography South Africa 4% Other Plastics Pharma- 4% Healthcare 36% Belgium 17% Ireland 6% 8% Tobacco Germany 13% 12% United States 3% France 34% 11% United Kingdom Branded Products 52% (Alcoholic drinks, confectioneries & cosmetics) 6 2005 Revenues
Slide 7: Paperboard Packaging
Paperboard Packaging 2005 Sales by Market • A European market leader in target markets • Products include: folding Tobacco cartons, booklets, leaflets, Pharma-Healthcare $132 labels, composite tubes, rigid $377 set-up boxes, vacuum-formed packaging • Sector-focused on key markets: – Pharmaceutical &
Slide 8: Plastic Packaging
Plastic Packaging 2005 Sales by Market • Leadership positions in selected niche markets Agrochemicals & – Barrier containers for invasive fluids Specialty Chemicals – PET soft drink bottles in South Africa $47 – HDPE milk bottles in Ireland • Products: HDPE bottles, containers and closures; PET bott
Slide 9: Broad Specialty Packaging Portfolio
Broad Specialty Packaging Portfolio 9
Slide 10: Innovative, Design-Focused Packaging Solutions
Innovative, Design-Focused Packaging Solutions Our award-winning design teams work with customers to develop innovative solutions for technically demanding, custom packaging applications • Partnered with GlaxoSmithKline in creating • Created a striking new six-color transparent gift an innovative de
Slide 11: Blue Chip Customers
Blue Chip Customers Wyeth’ syngenta Dy ALLIED DOMECQ Nestlé <= Nestle =} Cenarty ra @. Dow AgroSciences DIAGEO Kec PEP X STIEFEL” Ens — . “Altadi s Cary MAGES Cigares France aa = STORCK Ae BRITISH AMERICAN y ) Q TOBACCO PHILP MORRIS i @® Schering-Plough —_ pernod Ricard
Slide 12: Pharmaceuticals & Healthcare Market
Pharmaceuticals & 36% Healthcare Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increasing use of lifestyle • Comprehensive design services drugs • Special packaging features • Aging population • Reduced delivery times • In
Slide 13: Branded Products Market
Branded Products 34% Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased consumer • Brand positioning/ marketing focus on differentiation in discerning promotional packaging global markets • Greater demand for anti- •
Slide 14: Tobacco Market
Tobacco 13% Market Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Good growth projected in • Supplier rationalization developing countries • Shift from soft to hard pack • Low/negative growth in • Advertising restrictions lead to
Slide 15: Plastics Markets
Plastics 17% Markets Attractive Demand Well Positioned to Meet Prospects Market Trends Key Demand Drivers: Customer Requirements/Needs: • Increased soft drink and • Lighter weight containers for mineral water consumption agrochemicals and other • Barrier containers for specialty chemicals with agroc
Slide 16: Creating Value
Creating Value Cost Savings Program - $25 million Organic Growth – Worldwide pharmaceutical packaging demand expected to grow 5% per year to 2009, CSK position with top 20 Pharmaceutical customers Enhanced Strategic Initiatives – Arlington Press, Shareholder South Africa, China Value Cost of Capital
Slide 17: Financial Review
A | ~+ Financial Review as =
Slide 18: Historical Financial Performance for Continuing Operations
Historical Financial Performance for Continuing Operations Sales EBITDA (1) 1,100 120 $116 $1,032 $1,042 1,000 $111 110 $886 $104 900 100 800 90 700 2003 2004 2005 2003 2004 2005 EPS (1) Other Financial Data $2.00 • $25 million global cost-savings program $1.48 initiated in fourth quarter 2005 $0.97
Slide 19: Consolidated 2004 vs 2005
Consolidated 2004 vs 2005 Income from Continuing Operations before interest, extinguishment of debt, and taxes (EBIT) ($ in millions) 60 (6) (6) 2 40 55 45 20 - (1)2005 adjusted EBIT excludes pre-tax losses of $312 million for goodwill impairment, $13.1 million for 19 restructuring charges, asset im
Slide 20: Consolidated Balance Sheet
Consolidated Balance Sheet ($ in Millions) Year End 2003 2004 2005 Assets Total Current Assets $ 309 $ 339 $ 280 Property, Plant & Equipment, Net 432 427 372 Goodwill 644 695 354 Other Assets 108 96 117 Total Assets $ 1,493 $ 1,557 $ 1,123 Liabilities and Stockholders' Equity (1) Total Current Liabi
Slide 21: Capital Structure
Capital Structure Year End ($ in Millions) 2003 2004 2005 Total Debt $ 487 $ 429 $ 433 Stockholders' Equity 570 712 295 Total Capital $ 1,057 $ 1,141 $ 728 Interest Coverage 2.6x 3.1x 3.2x ( Adjusted EBITDA / Interest) Total Leverage 4.4x 3.7x 4.2x (Total debt / Adjusted EBITDA) 21
Slide 22: Business Segment Sales
Business Segment Sales Paperboard Plastics 900 $865 $860 200 $182 800 $167 $753 150 700 $132 600 100 500 50 400 300 0 2003 2004 2005 2003 2004 2005 22
Slide 23: Paperboard Business Segment
Paperboard Business Segment EBITDA EBITDA Margin 120 16 13.8% 14 $104 11.4% $99 12 11.3% 100 $97 10 8 6 80 4 2 60 0 2003 2004 2005 2003 2004 2005 23
Slide 24: Plastics Business Segment
Plastics Business Segment EBITDA EBITDA Margin 40 20 17.4% 15.6% 30 $26 $25 15 13.7% $23 20 10 10 5 0 0 (1) (1) 2003 2004 2005 2003 2004 2005 (1) 2004 Plastics EBITDA excludes pre-tax gain on sale of non-strategic land of $5.8 million. 24
Slide 25: Cash Flow
Cash Flow Cash flow available for shareholders and debt reduction 80 $73 60 $43 40 20 $12 0 (1) 2003 2004 2005 (1) 25 2005 excludes cash outflows of $78.4 million for acquisitions
Slide 26: Cost Savings Program
Cost Savings Program • 2 year program - 2006/2007 • Target annualized savings $25 million • Estimated restructuring charges $30 – 40 million • Initiatives focused on: – Sale or closure of underperforming assets – Process improvement & operational efficiency – General workforce & overhead reduction •
Slide 27: Cost Savings Program
Cost Savings Program Initiatives Underway • Closures – Birmingham England (Food & Household operation) – Bedford England (Pharma/Healthcare operation) – Ezy France (Luxury Packaging operation) • General workforce reduction activities • Sale of Lurgan, Northern Ireland (Food & Beverage operation) 27
Slide 28: Investment Highlights
Investment Highlights A leading supplier of value-added, specialty paperboard packaging in Europe A leading supplier of specialty plastic packaging products to niche end-use markets Focus on higher growth, lower cyclicality end-use markets that require rigorous process & quality control, brand posit
Slide 29: Financial Reconciliations
Financial Reconciliations Reconciliation of Adjusted EBITDA and Adjusted EBIT to EBIT ($ in Millions) Year-Ended December 28, January 2, January 1, 2003 2005 2006 Sales from continuing operations: Paperboard Packaging $753.4 $864.7 $860.2 Plastic Packaging 132.2 167.0 181.8 $885.6 $1,031.7 $1,042.0
Slide 30: Financial Reconciliations
Financial Reconciliations Reconciliation of Cash Flow Available for Shareholders and Debt Reduction to Net Cash Provided by Operating Activities ($ in Millions) Year-Ended December 28, January 2, January 1, 2003 2005 2006 Cash flow available for shareholders & debt reduction $43.3 $72.6 $12.4 Add: N
Slide 31: Investing In Chesapeake
Investing In Chesapeake April 2006